German federal health officials are under suspicion of taking bribes from a Japanese pharmaceutical company that wanted permission to sell a medicine with reported harmful side effects, according to prosecutors, AP reports from Frankfurt.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments